ArticleOncology letters2025
Submandibular adenoid cystic carcinoma presenting with liver metastasis as the initial symptom: A case report.
Article in Oncology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adenoid cystic carcinoma (ACC) is a rare and aggressive malignancy characterized by a high incidence of distant metastasis. However, cases of ACC with liver and lymph node metastases are rarely reported and lack a standardized treatment consensus. The present report describes the case of a submandibular gland ACC with liver metastasis manifesting as the initial symptom. PET/CT revealed masses in the left submandibular gland and the liver. The patient underwent right tri-lobe hepatectomy and resection of the submandibular gland tumor. Histological examination of the tumor revealed a cribriform type with both lymphovascular invasion and perineural invasion. New lymph node metastases were observed 21 months after surgery of the submandibular gland tumor, and no further treatment was administered to date. The patient has survived for 28 months since the diagnosis of liver metastasis and currently exhibits stable vital signs. In conclusion, the present case illustrates a rare, high-risk variant of rapidly progressing submandibular gland ACC, with liver metastasis serving as the initial presenting symptom. A multidisciplinary approach is essential for the effective management of complex metastatic ACC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.